Our press documents

You are a journalist and you would like to receive our press releases by e-mail? Please, ask to presse@pasteur.fr

Filter press documents

Covid-19 : la durée de la réponse immunitaire neutralisante plus longue chez les femmes que chez les hommes
Press Info
07.03.2021
As part of the SEROCoV-HUS study, teams from Strasbourg University Hospital and the Institut Pasteur monitored 308...
Press Info
26.02.2021
A year into the pandemic, and confronted with continued resurgence in transmission, over 800 million schoolchildren,...
Press release
18.02.2021
Monoclonal antibodies are part of the therapeutic arsenal for eliminating cancer cells. Some make use of the immune...
Press Info
12.02.2021
The COVID-19 pandemic has devastated health-care systems, shut down schools and communities, and plunged the world into...
Press release
12.02.2021
What if more inclusive urban planning for poor populations was key to fighting dengue fever? This is what researchers...
Covid-19 Essai Clinique
Press release
25.01.2021
Since early 2020, the Institut Pasteur has been engaged in research in several of its areas of scientific expertise,...
COVID-19 : un projet vaccin lentiviral par voie intra-nasale assure une protection importante chez l’animal
Press release
19.01.2021
Scientists from the Institut Pasteur-TheraVectys Joint Laboratory recently published in Cell Host & Microbe1 the...
Press release
28.12.2020
Throughout the world, long-term care facilities have been high-risk sites for virus spread since the emergence of the...
Press release
17.12.2020
The Institut Pasteur, in partnership with the French National Health Insurance Fund (CNAM), Santé publique France and...

Pages

 

Subscribe to our newsletter

Back to top